发明授权
US4605655A Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
失效
抗精神病药1-氟苯基丁基-4-(2-嘧啶基)哌嗪衍生物
- 专利标题: Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
- 专利标题(中): 抗精神病药1-氟苯基丁基-4-(2-嘧啶基)哌嗪衍生物
-
申请号: US683309申请日: 1984-12-18
-
公开(公告)号: US4605655A公开(公告)日: 1986-08-12
- 发明人: Joseph P. Yevich , Walter G. Lobeck, Jr.
- 申请人: Joseph P. Yevich , Walter G. Lobeck, Jr.
- 申请人地址: NY New York
- 专利权人: Bristol-Myers Company
- 当前专利权人: Bristol-Myers Company
- 当前专利权人地址: NY New York
- 主分类号: C07D239/42
- IPC分类号: C07D239/42 ; A61K20060101 ; A61K31/505 ; A61P25/18 ; C07D20060101 ; C07D239/00 ; C07D239/47 ; C07D317/00 ; C07D317/12 ; C07D403/04 ; C07D405/12 ; C07D405/14
摘要:
Disubstituted N,N-piperazinyl derivatives are disclosed wherein one substituent is a pyrimidin-2-yl ring and the other is a 4 carbon chain attached to a p-fluorophenyl ring at the terminal carbon. The terminal carbon of this butylene chain is also bonded to an oxygen atom as part of a carbonyl, carbinol, or ketal functionality. These compounds possess psychotropic properties, particularly atypical antipsychotic activity of good duration. By virtue of pre-clinical pharmacological testing, these compounds appear useful as potential antipsychotic agents which lack the typical movement disorder side-effects of standard antipsychotic agents.
公开/授权文献
- US5760629A DC offset compensation device 公开/授权日:1998-06-02
信息查询